Objective: To explore the clinical effect of rupatadine fumarate. Method: 120 cases of allergic rhinitis were divided into two groups, one group for the experimental group, rupatadine fumarate will be treated, and the control group take the treatment of cetirizine hydrochloride tablets. Compare the efficacy and safety of two other indicators. Result: After 2 weeks of treatment, the clinical efficacy of the experimental group was better than the control group level (He value = 4. 7069, P value = 0. 0300) , the incidence of experimental group ' s adverse reactions ( 1. 67% ) was lower than the control group ( 13. 33% ) , the data statistically significant difference (P <0.05). Conclusion: Rupatadine fumarate in treatment of allergic rhinitis is better than cetirizine hydrochloride tablets, and adverse reactions is less. Recommended for clinical use.%目的:探讨富马酸卢帕他定的临床疗效.方法:将120例过敏性鼻炎患者分为两组.实验组采用富马酸卢帕他定治疗,对照组采用盐酸西替利嗪片治疗.比较两组的临床疗效及安全性等指标.结果:两组病人用药后2周实验组的临床疗效等级明显优于对照组(Hc值=4.7069,P值=0.0300),实验组的不良反应发生率(1.67%)低于对照组(13.33%),数据差异具有统计学意义(P<0.05).结论:富马酸卢帕他定片治疗过敏性鼻炎效果优于盐酸西替利嗪片,不良反应少,值得临床推广使用.
展开▼
